The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis

Archive ouverte

Nampoothiri, Sreekala | Sauve, Florent | Ternier, Gaëtan | Fernandois, Daniela | Coelho, Caio | Imbernon, Monica | Deligia, Eleonora | Perbet, Romain | Florent, Vincent | Baroncini, Marc | Pasquier, Florence | Trottein, François | Maurage, Claude-Alain | Mattot, Virginie | Giacobini, Paolo | Rasika, S. | Prevot, Vincent

Edité par CCSD -

Abstract Most patients with COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), display neurological symptoms, and respiratory failure in certain cases could be of extra-pulmonary origin. Hypothalamic neural circuits play key roles in sex differences, diabetes, hypertension, obesity and aging, all risk factors for severe COVID-19, besides being connected to olfactory/gustative and brainstem cardiorespiratory centers. Here, human brain gene-expression analyses and immunohistochemistry reveal that the hypothalamus and associated regions express angiotensin-converting enzyme 2 and transmembrane proteinase, serine 2, which mediate SARS-CoV-2 cellular entry, in correlation with genes or pathways involved in physiological functions or viral pathogenesis. A post-mortem patient brain shows viral invasion and replication in both the olfactory bulb and the hypothalamus, while animal studies indicate that sex hormones and metabolic diseases influence this susceptibility.

Consulter en ligne

Suggestions

Du même auteur

Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death. La sénescence cellulaire, nouvelle cible des infections virales respiratoires : du virus influenza au SARS-CoV-2

Archive ouverte | Sauve, Florent | CCSD

International audience. BackgroundWe have recently demonstrated a causal link between loss of gonadotropin-releasing hormone (GnRH), the master molecule regulating reproduction, and cognitive deficits during patholo...

Estrogen receptor-α signaling in tanycytes lies at the crossroads of fertility and metabolism

Archive ouverte | Fernandois, Daniela | CCSD

International audience

Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions

Archive ouverte | Imbernon, Monica | CCSD

International audience. Liraglutide, an anti-diabetic drug and agonist of the glucagon-like peptide one receptor (GLP1R), has recentlybeen approved to treat obesity in individuals with or without type 2 diabetes. De...

Chargement des enrichissements...